Legal & General Group PLC Oncternal Therapeutics, Inc. Transaction History

Legal & General Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.83 - $17.8 $2,933 - $62,905	-3,534 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$4.75 - $9.39 $16,786 - $33,184	3,534 New	3,534 $17,000
Q3 2019 Nov 13, 2019	SELL	$3.87 - $6.13 $375 - $594	-97 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.86 - $9.24 $471 - $896	97 New	97 $1,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.